Twist Bioscience Corporation
TWSTBiological Products, (No Disgnostic Substances) · Avg daily volume 2.0M · fiscal year ends Sep$205.00+16.33+8.66%Volume 3.2M+62% vs avg
Quarterly earnings
Latest filing: 10-Q, 2026-08-03Mar ’24FQ2 ’24
Jun ’24FQ3 ’24
Sep ’24Q4FQ4 ’24
Dec ’24FQ1 ’25
Mar ’25FQ2 ’25
Jun ’25FQ3 ’25
Sep ’25Q4FQ4 ’25
Dec ’25FQ1 ’26
Mar ’26FQ2 ’26
Jun ’26FQ3 ’26
EPS
EPS
−$0.79
−$1.47
−$0.59
−$0.53
−$0.66
$0.33
−$0.45
−$0.50
−$0.71
−$0.56
% chg
+24%
−46%
+27%
+29%
+17%
+122%
+24%
+6%
−8%
−270%
Sales
75.3M
81.5M
84.7M
88.7M
92.8M
96.1M
99.0M
103.7M
110.7M
118.4M
% chg
+25%
+28%
+27%
+24%
+23%
+18%
+17%
+17%
+19%
+23%
Filed
05/02
08/02
11/18
02/03
05/05
08/04
11/17
02/02
05/04
08/03
EPS growth ≥ 25%0–25%fallingno comparison
Source: SEC EDGAR 10-Q and 10-K filings, loaded the first time a stock is opened and refreshed daily. Q4 = full year minus the first three quarters. Growth from a loss is measured against the size of the loss (−$1 → $2 = +300%). Analyst estimates are not in EDGAR.